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Dear  Editor,
Plasmacytic  hepatic  lymphoma  is  a  rare  type  of  tumour
whose  presentation  may  be  misleading  on  imaging.  This  is  a
case  report  about  a  50-year-old  man  with  a  history  of  non-
Hodgkin’s  lymphoma  (NHL)  treated  by  chemotherapy  and
who  had  been  in  remission  for  6  years.  CT  scan  monitor-
ing  revealed  a  large,  hypoattenuating  hepatic  lesion  with
no  calciﬁcations.  No  involvement  of  peripheral  or  distant
lymph  nodes  or  splenomegaly  or  other  visceral  lesions  were
observed.  Abdominal  MR  imaging  examination  (Figs.  1—4)
conﬁrmed  the  presence  of  a  well-delineated,  lobulated  mass
located  in  segments  6,  7  and  8  and  measuring  18  ×  13  cm
in  the  axial  plane.  The  lesion  was  hyperintense  on  T2-
weighted  images  and  showed  rapid  enhancement  after
Figure 1. MRI, axial T2-weighted slice. A well-delimited, mod-
erately hyperintense liver lesion with a lobulated contour and a
markedly hyperintense central scar (arrow) is visible in segments
VI, VII and VIII.
Figure 2. During the arterial phase of the gadolinium chelate
injection, moderate, heterogeneous, early enhancement of the
lesion was observed with no enhancement of the scar (arrow).
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2211-5684/© 2015 Published by Elsevier Masson SAS on behalf of the Édiigure 3. Homogenization of the lesion in the venous phase.ntravenous  administration  of  a gadolinium  chelate.  The
esion  was  surrounded  by  a  hypointense  capsule  presenting
reas  of  retraction  in  contact  with  the  lesion  with  a  ﬁnger-
haped  central  area,  hyperintense  on  T2-weighted  images
tions françaises de radiologie.
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Figure 4. Discrete slow enhancement of the central scar (arrow)
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lnd the tumor capsule, revealing capsular retraction adjacent to
egment VII.
nd  showing  slow  enhancement  after  contrast  injection.
natomopathological  examination  of  tissue  sample  obtained
y  percutaneous  puncture  of  the  lesion  revealed  the  pres-
nce  of  a  plasmacytic  hepatic  lymphoma  (Figs.  5  and  6).
iscussion
n  imaging,  hepatic  lymphoma  often  presents  as  solitary
esion  with  diameter  of  up  to  20  cm  [1]. A  central  area
howing  slow  enhancement  mirrors  that  of  focal  nodu-
ar  hyperplasia  and  ﬁbrolamellar  hepatocellular  carcinomas
2,3].
The  MR  imaging  features  of  the  lobulated  lesion  that
nhances  rapidly  after  gadolinium-chelate  injection  with
 central  stellar  area  that  enhances  slowly  is  suggestive
f  ﬁbrolamellar  hepatocellular  carcinoma  in  which  central
alciﬁcations  may  be  present  in  50%  of  tumors  as  well  as
reas  of  necrosis  [2,3].  Enhancement  was  intense  but  het-
rogeneous  with  no  enhancement  of  the  central  part,  which
igure 5. H&E histological section, × 400: atypical, plasmacytic-
ike round cells.
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[igure 6. CD138 immunohistochemistry analysis, × 400: tumour
opulation frankly and unequivocally positive.
as  hypointense  in  T1-  and  T2-weighted  images.  However,
elayed  enhancement  of  the  scar  was  unusual  [2,3].
Capsular  retraction  adjacent  to  a  hepatic  tumour  is  very
uggestive  for  malignancy,  being  associated  with  epithelioid
emangioendotheliomas,  intrahepatic  cholangiocarcinomas
nd  breast  cancer  liver  metastases  [4,5].  However,  the  sign
s  not  pathognomonic  because  it  has  also  been  described
ith  benign  tumours  such  as  sclerosing  hemangiomas  [4,5].
The  prevalence  of  hepatic  lymphomas  secondary  to  NHL
s  estimated  to  be  between  15  and  60%  [6,7]. Diagnosis  and
ocalisation  of  lymphoproliferative  disease  in  the  liver  is
asy  when  the  lymphoid  cell  inﬁltrate  has  the  same  cyto-
ogical  and  immunohistochemical  features  as  the  primary
ymph  node  lesion  [7].  Splenic  involvement  is  almost  always
resent.
The  criteria  used  for  the  diagnosis  of  primary  NHL  of  the
iver  are  the  presence  of  a  solitary  hepatic  lesion  with  no
ymph  node  involvement  or  splenomegaly  or  other  visceral
esions  and  an  absence  of  concomitant  haematological  disor-
ers  [7]. 18FDGPET/CT  scanning  is  very  useful  for  assessing
he  extent  of  lymphoma  and  to  conﬁrm  that  the  tumour  has
 single  location  [8].
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